How We WorkOrder NowSupport Privacy

Day Movers Of The Healthcare Sector – Inovio Pharmaceuticals Inc (NYSEAMEX:INO), Array Biopharma Inc (NASDAQ:ARRY).

on 26/03/2013

Houston, TX – March 26, 2013 — (Net PR News) – offers its daily alerts and market content newsletter to investors looking for the best information available! provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit

 Today’s Stocks in focus are: INO, ARRY

Trend analysis report of the Biotechnology industry of the Healthcare sector stocks, Inovio Pharmaceuticals Inc (NYSEAMEX:INO) was showing negative momentum during the previous trade and Array Biopharma Inc (NASDAQ:ARRY) remained in the news during the last trading session due to their latest news, upward movement and sizzling activities.

Inovio Pharmaceuticals Inc (NYSEAMEX:INO) revealed that its total operating expenses remained $7.4 million for the 4th Q, and $27.6 million for the FY 2012, in comparison to the last year 4th Q of $7.4 million, and $31.4 million for the last year.

Is INO a Solid Investment at These Levels? Read This Report For Details

Healthcare sector stock showing a negative trend during last trade, Inovio Pharmaceuticals Inc (NYSEAMEX:INO) remained among the day decliners and traded with volume of 2.44 million shares in the last session, as compared to average volume of 1.68 million shares.

The stock on Monday decreased -4.23% and finished the day at $0.555. The 52 week range of the stock remained $0.38 – $0.83. INO was a gainer in the 5 days activity and jumped about 2.21%. The one month performance of stock was negative and it declined more than -14%.

How Should Investors Trade INO Now? Don’t Miss out on a Special Trend Analysis

Array Biopharma Inc (NASDAQ:ARRY) reported that, as a Chief Medical Officer of the company, Michael N. Needle, M.D. has been appointed.

Biotechnology company moving upward during the previous trading session, Array Biopharma Inc (NASDAQ:ARRY) opened at the price of $4.61, whereas its previous closing price was recorded at $4.64. ARRY surged +8.16% and traded within the range of $4.51 – $4.90 for the day. The 52 week range of the stock remained in between $3.00 – $6.17.

What Are ARRY’s Charts Signaling for Traders? Find Out Here

Company’s total market capitalization stands at $541.31 billion along with 116.66 million outstanding shares. Total volume of the stock was 2.33 million shares during last trade, while its average volume is 823,391.00 shares.


Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Source: anotherwinningtrade Posted Tue, March 26, 2013 12:54 - Permalink